July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
An Intraocular Pressure Predictive of High-Risk Histopathologic Features in Group E Retinoblastoma Eyes
Author Affiliations & Notes
  • Mary Elizabeth Kim
    The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, United States
    USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
  • Sona Shah
    The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, United States
    USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
  • Emily Zolfaghari
    The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, United States
  • Rima Jubran
    The Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Mark W. Reid
    The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, United States
  • Jonathan W. Kim
    The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, United States
    USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
  • Jesse L Berry
    The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, United States
    USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Mary Kim, None; Sona Shah, None; Emily Zolfaghari, None; Rima Jubran, None; Mark Reid, None; Jonathan Kim, None; Jesse Berry, None
  • Footnotes
    Support  The Larry and Celia Moh Foundation; The Institute for Families, Inc., Children's Hospital Los Angeles; An unrestricted departmental grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2330. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mary Elizabeth Kim, Sona Shah, Emily Zolfaghari, Rima Jubran, Mark W. Reid, Jonathan W. Kim, Jesse L Berry; An Intraocular Pressure Predictive of High-Risk Histopathologic Features in Group E Retinoblastoma Eyes. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2330.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the intraocular pressure (IOP), with or without neovascularization of the iris (NVI), that most accurately predicts the presence of high-risk histopathologic features, including post-laminar optic nerve invasion, massive choroidal invasion, and extra-scleral invasion.

Methods : A retrospective chart review was done on 118 enucleated Group E eyes with numerical IOP recorded at diagnosis and documentation of the presence or absence of high-risk histopathologic features.

Results : The mean IOP at diagnosis for eyes with high-risk pathology (31.8 mm Hg) was significantly higher than the mean IOP at diagnosis for eyes without high-risk pathology (24.5 mm Hg) (p = 0.0031). An IOP cutoff value of 34 mm Hg optimizes specificity (82.4%) in predicting the presence of high-risk histopathologic features, as eyes with an IOP ≥ 34 mm Hg at diagnosis were 5.91 times more likely to have high-risk histopathologic features than those with an IOP < 34 mm Hg at diagnosis. Furthermore, having an IOP ≥ 34 mm Hg at diagnosis was more predictive of high-risk histopathology than either the presence or absence of NVI.

Conclusions : Whether or not NVI occurs, Group E eyes with an IOP ≥ 34 mm Hg at diagnosis are 5.91 times more likely to have high-risk histopathologic features than eyes with an IOP below this value. Thus, any attempts at salvage or unnecessary delay in enucleation for these eyes may predispose the child to unnecessary metastatic risk.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×